Home
>
National Drug Code (NDC)
>
Gabapentin
Gabapentin - 59063-127-47 - (gabapentin)
Drug Information of Gabapentin
| Product NDC: | 59063-127 |
| Proprietary Name: | Gabapentin |
| Non Proprietary Name: | gabapentin |
| Active Ingredient(s): | 250 mg/5mL & nbsp; gabapentin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Gabapentin
| Product NDC: | 59063-127 |
| Labeler Name: | Kiel Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076403 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120501 |
Package Information of Gabapentin
| Package NDC: | 59063-127-47 |
| Package Description: | 470 mL in 1 BOTTLE (59063-127-47) |
NDC Information of Gabapentin
| NDC Code | 59063-127-47 |
| Proprietary Name | Gabapentin |
| Package Description | 470 mL in 1 BOTTLE (59063-127-47) |
| Product NDC | 59063-127 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | gabapentin |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20120501 |
| Marketing Category Name | ANDA |
| Labeler Name | Kiel Laboratories, Inc. |
| Substance Name | GABAPENTIN |
| Strength Number | 250 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
